Our Board of Directors is a group of people who meet a set of General Criteria for membership and are elected to the Board by our shareholders each year. We currently have 11 Board members, 10 of whom are "independent" under the rules of the New York Stock Exchange.
Our Board holds the ultimate authority of our Company, except to the extent that shareholders are granted certain powers under the Company's Certificate of Incorporation and By-Laws.
The Board:
Our Management Team meets throughout each year with our Board members to discuss strategic direction and major developments of the Company's various businesses.
Our Directors are:
Mary Sue Coleman, Ph.D.
President, University of Michigan
James G. Cullen
Retired President and Chief Operating Officer, Bell Atlantic Corporation
Michael M.E. Johns, M.D.
Chancellor, Emory University
Arnold G. Langbo
Retired Chairman and Chief Executive Officer, Kellogg Company
Susan L. Lindquist, Ph.D.
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology
Anne M. Mulcahy
Chairman, Xerox Corporation
Leo F. Mullin
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc.
William D. Perez
Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company
Charles Prince
Chairman, Sconset Group LLC; Vice Chairman and Chairman of the Board of Advisors, Stonebridge International LLC; Retired Chairman and Chief Executive Officer, Citigroup Inc.
David Satcher, M.D., Ph.D.
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine
William C. Weldon
Chairman, Board of Directors and Chief Executive Officer, Chairman, Executive Committee
Find out more about:
Director Nomination Process
Strategic Planning Process
Communication with the Board
Board Committees
Our Management Team
Certificate of Incorporation